Grapheal raises €1.9m to develop graphene-based biosensors
The Grapheal team. Image: Grapheal
The medtech start-up will use the funds to support the development of a digital Covid-19 test and wound-monitoring biosensors.
As the pandemic continues, many start-ups in the health space have seen an influx of investment. According to Pitchbook’s European Venture Report for 2020, investment in biotech and pharma start-ups jumped by more than 40pc year-on-year.
Now, a French medtech company specialising in graphene-based wearable sensors has secured €1.9m in equity and non-dilutive sources.
Founded in 2019, Grapheal develops wearable and disposable sensors that enable continuous monitoring and diagnosis. The company is a spin-out from the Neel Institute at the French National Centre for Scientific Research.